Tuesday, August 25, 2026 | 11:00 AM ISTहिंदी में पढें
ERIS Lifesciences Ltd News
Eris Lifesciences Q4 profit jumps three-fold to ₹281.6 cr; shares surge 11%
The pharmaceutical company reported robust growth in domestic formulations and insulin franchise performance, while maintaining a strong EBITDA margin of 37 per cent
 "Eris Lifesciences Q4 profit jumps three-fold to ₹281.6 cr; shares surge 11%")
Updated On : 20 May 2026 | 5:03 PM IST
10 pharma firms launch semaglutide in India; Nomura sees ₹12k-cr mkt
Companies including Dr. Reddy's Laboratories, Sun Pharma, Zydus Lifesciences, Natco Pharma, Alkem Laboratories, and Torrent Pharmaceuticals have developed their own formulations
 "10 pharma firms launch semaglutide in India; Nomura sees ₹12k-cr mkt")
Updated On : 23 Mar 2026 | 9:58 AM IST